Showing results (1-10 of 27) with videos related to
Sort By:
Pageof 3
The Journal of Antimicrobial Chemotherapy|August 27, 2005
The place for itraconazole in treatmentJohan Maertens, Marc BoogaertsInternational Journal of Infectious Diseases : IJID : Official Publication of the International Society for Infectious Diseases|July 4, 2003
Caspofungin in the treatment of candidosis and aspergillosisJohan Maertens, Marc BoogaertsDrug Design, Development and Therapy|January 8, 2010
Development of fludarabine formulations in the treatment of chronic lymphocytic leukemiaAnn Janssens, Marc Boogaerts, Gregor VerhoefOncology|October 26, 2005
Beyond anaemia management: evolving role of erythropoietin therapy in neurological disorders, multiple myeloma and tumour hypoxia modelsMarc Boogaerts, Moshe Mittelman, Peter VaupelLeukemia Research|April 12, 2003
Amifostine does not preferentially stimulate the growth of residual polyclonal progenitor cells in myelodysplastic syndromesMichel Delforge, Vicky Raets, Victor Van Duppen, et al.Leukemia Research|November 17, 2007
The clinical significance of activated lymphocytes in patients with myelodysplastic syndromes: a single centre study of 131 patientsStef Meers, Peter Vandenberghe, Marc Boogaerts, et al.Nature Clinical Practice. Cardiovascular Medicine|February 28, 2006
Bone marrow cell transfer in acute myocardial infarctionStefan Janssens, Koen Theunissen, Marc Boogaerts, et al.Supportive Cancer Therapy|July 18, 2008
Effect of treatment with epoetin Beta on thromboembolic events in anemic patients with cancer: a metaanalysisBertrand Coiffier, Marc Boogaerts, Matti Aapro, et al.Leukemia Research|December 26, 2006
Immature and mature monocyte-derived dendritic cells in myelodysplastic syndromes of subtypes refractory anemia or refractory anemia with ringed sideroblasts display an altered cytokine profileLing Ma, Jan Ceuppens, Ahmad Kasran, et al.The Journal of Infectious Diseases|October 29, 2002
Use of circulating galactomannan screening for early diagnosis of invasive aspergillosis in allogeneic stem cell transplant recipientsJohan Maertens, Johan Van Eldere, Jan Verhaegen, et al.Pageof 3